BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30239392)

  • 1. MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis.
    Kelley KA; Wieghard N; Chin Y; Potter A; Mori M; Wong MH; Chin K; Tsikitis VL
    Dis Colon Rectum; 2018 Nov; 61(11):1290-1296. PubMed ID: 30239392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
    Li W; Chang J; Tong D; Peng J; Huang D; Guo W; Zhang W; Li J
    Oncotarget; 2017 May; 8(22):35783-35791. PubMed ID: 28415758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease.
    Chang KH; Miller N; Kheirelseid EA; Lemetre C; Ball GR; Smith MJ; Regan M; McAnena OJ; Kerin MJ
    Int J Colorectal Dis; 2011 Nov; 26(11):1415-22. PubMed ID: 21739196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
    Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
    Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study.
    Aslam MI; Venkatesh J; Jameson JS; West K; Pringle JH; Singh B
    Colorectal Dis; 2015 Jul; 17(7):578-88. PubMed ID: 25557290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    Heublein S; Albertsmeier M; Pfeifer D; Loehrs L; Bazhin AV; Kirchner T; Werner J; Neumann J; Angele MK
    BMC Cancer; 2018 Feb; 18(1):201. PubMed ID: 29463215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
    Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
    BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer.
    Vychytilova-Faltejskova P; Pesta M; Radova L; Liska V; Daum O; Kala Z; Svoboda M; Kiss I; Slaby O
    Cancer Genomics Proteomics; 2016; 13(4):311-6. PubMed ID: 27365381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.
    Schrijver WA; van Diest PJ; ; Moelans CB
    Oncotarget; 2017 Jan; 8(2):3111-3123. PubMed ID: 27902972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
    Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
    Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
    Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
    Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
    Rinnerthaler G; Hackl H; Gampenrieder SP; Hamacher F; Hufnagl C; Hauser-Kronberger C; Zehentmayr F; Fastner G; Sedlmayer F; Mlineritsch B; Greil R
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.
    Wanram S; Klaewkla N; Pinyosri P
    Microrna; 2024; 13(1):56-62. PubMed ID: 38231064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.